June 17, 2021, at 2:00 p.m. ET (1 hour)
Like most of the healthcare system, the COVID-19 pandemic interrupted colorectal cancer care pathways, but there is opportunity to get back on track and realize greater value for both patients and health systems.
This webinar draws on key findings from The Conference Board of Canada’s report Value-based analysis of patient care pathways in oncology: Focus on colorectal cancer in Ontario and Quebec.
Moderated by Barry D. Stein, President of Colorectal Cancer Canada, the session will engage our panelists representing clinician champions and patient advocacy group leaders in a dynamic discussion on the opportunities for deriving more value from colorectal care pathways in Ontario and Quebec.
Join us to explore:
Please join Dr. Gerald Batist, Director, McGill Centre for Translational Research in Cancer; Dr. Bill Evans, Professor Emeritus, Department of Oncology, McMaster University; Eva Villalba, Executive Director, Quebec Cancer Coalition; and Barry Stein, President and CEO, Colorectal Cancer Canada for this engaging discussion.
Thank you to all our Value-Based Healthcare sponsors for making this webinar possible.
Professor Emeritus, Department of Oncology, McMaster University
Dr. Bill Evans is a medical oncologist who practiced at the Toronto General Hospital for 10 years before moving to Ottawa as the Chief Executive Officer of the Ottawa Regional Cancer Centre. He came back to Toronto in 2000, as the provincial head of systemic therapy and Chief Medical Officer at Cancer Care Ontario. In 2005, he went to Hamilton as the President of the Juravinski Hospital and Cancer Centre at Hamilton Health Sciences.
He “semi-retired” in June 2013 and is now Professor Emeritus in the Department of Oncology, McMaster University but stays active with his own consulting business and as CCO’s Clinical Advisor on Smoking Cessation.
Dr. Evans has published over 300 publications in peer-reviewed journals on various aspects of lung cancer treatment, smoking cessation, and the cost and cost-effectiveness of cancer care.
Director, McGill Centre for Translational Research in Cancer
Dr. Batist is a medical oncologist and molecular pharmacologist. He is Director of the McGill Centre for Translational Research in Cancer, which was established to stimulate rapid translation of new discoveries in the research laboratory into clinical benefits for patients.
A major award from the Canadian Foundation for Innovation led to the expansion of the Translational Research Centre into the Segal Cancer Centre at the Jewish General Hospital. Dr. Batist is a former Chairman of the McGill University Department of Oncology, and helped found and directs multiple local and global initiatives in Precision Medicine.
His scientific focus is therapeutic resistance, and he has 200 publications. He is a member of several scholarly associations, and serves on editorial boards and on advisory committees.
Executive Director, Quebec Cancer Coalition
Eva Villalba is the Executive Director of the Quebec Cancer Coalition, a non-profit patient advocacy group dedicated to improving the Quebec health-care system for people affected by cancer. Since 2008, she has been involved in health-care charities, advocacy groups and non-profits. She graduated from McGill University with double majors in Psychology and Applied Linguistics, then completed an MBA from HEC Montréal in order to apply best business practices to the non-profit sector.
She is currently completing an MSc. in Health Care Transformation at the UT Austin: Value Institute for Health & Care with the goal of sharing Value-Based Health Care (VBHC) expertise in Quebec and Canada. Eva is passionate about good governance, government relations, public policy, community impact, health-care transformation and social innovation.
President and CEO, Colorectal Cancer Canada
Barry D. Stein is the president and CEO of the Colorectal Cancer Canada (CCC), a not-for-profit colorectal cancer patient organization dedicated to colorectal cancer awareness and education, supporting patients and their caregivers and advocating on their behalf. Barry actively represents the interests of cancer patients and speaks regularly to medical professionals, industry, government, and patient groups across Canada and internationally.
Barry is the past president of the Coalition Priorité Cancer au Québec and a member of its Board of Directors. He is a founding member of the Canadian Partnership Against Cancer National Colorectal Cancer Screening Network and a member of the Board of Directors of the Canadian Personalized Healthcare Innovation Network (CPHIN). He is also the past chair of the IQVIA Advisory Council for the Advancement of Health in Quebec and a member the Board of Directors (Observer) of the Le Consortium de recherche en oncologie clinique du Québec (Q-CROC).